Papenburg, J., Defoy, I., Massé, E., Caouette, G., & Lebel, M. H. (2020). Impact of the Withdrawal of Palivizumab Immunoprophylaxis on the Incidence of Respiratory Syncytial Virus (RSV) Hospitalizations Among Infants Born at 33 to 35 Weeks’ Gestational Age in the Province of Quebec, Canada: The RSV-Quebec Study. J Pediatric Infect Dis Soc.
シカゴスタイル引用形Papenburg, Jesse, Isabelle Defoy, Edith Massé, Georges Caouette, , Marc H. Lebel. "Impact of the Withdrawal of Palivizumab Immunoprophylaxis On the Incidence of Respiratory Syncytial Virus (RSV) Hospitalizations Among Infants Born At 33 to 35 Weeks’ Gestational Age in the Province of Quebec, Canada: The RSV-Quebec Study." J Pediatric Infect Dis Soc 2020.
MLA引用形式Papenburg, Jesse, et al. "Impact of the Withdrawal of Palivizumab Immunoprophylaxis On the Incidence of Respiratory Syncytial Virus (RSV) Hospitalizations Among Infants Born At 33 to 35 Weeks’ Gestational Age in the Province of Quebec, Canada: The RSV-Quebec Study." J Pediatric Infect Dis Soc 2020.